Tissue Chips: The Greatest Technology You've Never Heard Of
Precision medicine will be available to everyone because of Tissue Chips. Hear the fascinating story of the most important technology you have never heard of before. In this episode of the Amazing Things Podcast, brought to you by United For Medical Research, we take you inside the Tissue Chip program - an NCATS collaboration with the Defense Advanced Research Projects Agency and FDA to support the development of bioengineered devices to improve the process of predicting whether drugs will be safe or toxic in humans.
Summary
In this episode of The Amazing Things Podcast, we talk to Dr. Lucie Low about tissue chip technology and its potential to change how we develop and test new drugs. Dr. Low is the Scientific Program Manager of the Tissue Chip for Drug Screening Program at the National Center for Advancing Translational Sciences (NCATS), part of the National Institute of Health.
Approximately 30 percent of promising medications have failed in human clinical trials because they are found to be toxic despite promising preclinical studies in animal models. Additionally, about 60 percent of drug candidates fail due to lack of efficacy. These currently unavoidable facts of the drug development process are one reason why there is so much excitement around tissue chips.